“sp2 is one of the most appreciated journals
I receive amongst many others. Its content,
structure, colours and quality of the paper
make it very attractive to open and read.;”
Jean-Marie Rosset, Sochinaz SA
“sp2 is a good source of information for me.”
Andrew Donaldson, Avecia Biotechnology
“sp2 is
showing the way – with informative articles and the
latest news from the industry, and excellent presentation”
Dr David Ager, DSM Pharmaceuticals Inc
“Scores highly for readability and balance between
news and solid, in-depth coverage oif key topics”
Dr Peter Jackson, VP Pharma Products, Avecia Pharmaceuticals
“sp2 provides
a refreshingly topical and informed landscape of the exciting new technical and
business opportunities being raised and seized by a fusion of the emerging biotech
and fine chemicals communities”
Dr Tony Scott, Director, Specialised Organic Chemicals Sector
Associaiton (SOCSA)
|
